Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lindner

Showing results (291-300 of 412) with videos related to

Pageof 42
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1983
Cell-type specificity and developmental expression of neural cell-surface components involved in cell interactions and of structurally related moleculesM Schachner, A Faissner, J Kruse, et al.
Cancer Research|July 10, 2007
Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3Sudhakar Kalakonda, Shreeram C Nallar, Daniel J Lindner, et al.
Oncogene|January 20, 2009
GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuringP Sun, S C Nallar, S Kalakonda, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 15, 2016
[Hyperthermic Isolated Limb Perfusion Combined with Tasonermin - a Perfusion Leakage Monitoring Technique]J Trnka, M Špaček, V Šírová, et al.
Journal of Cell Science|November 24, 2021
Retraction: Identification and characterization of GRIM-1, a cell-death-associated gene productEdward R Hofmann, Shreeram C Nallar, Limei Lin, et al.
Ejhaem|January 29, 2025
Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferationXiaoxian Zhao, Deepa Jagadeesh, Juraj Bodo, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administrationS N Pavlou, K D Dahl, G Wakefield, et al.
In Vivo (Athens, Greece)|January 14, 1998
PET with hydroxytryptophan as tracer in hormone-refractory prostatic adenocarcinoma: evaluation of decarboxylation in vivoK M Kälkner, S Nilsson, M Bergström, et al.
Synapse (New York, N.Y.)|January 1, 1997
L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primatesJ Tedroff, R Torstenson, P Hartvig, et al.
Diabetologia|December 1, 1996
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upM Hanefeld, S Fischer, U Julius, et al.
Pageof 42

Showing results (291-300 of 412) with videos related to

Sort By:
Pageof 42
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1983
Cell-type specificity and developmental expression of neural cell-surface components involved in cell interactions and of structurally related moleculesM Schachner, A Faissner, J Kruse, et al.
Cancer Research|July 10, 2007
Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3Sudhakar Kalakonda, Shreeram C Nallar, Daniel J Lindner, et al.
Oncogene|January 20, 2009
GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuringP Sun, S C Nallar, S Kalakonda, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 15, 2016
[Hyperthermic Isolated Limb Perfusion Combined with Tasonermin - a Perfusion Leakage Monitoring Technique]J Trnka, M Špaček, V Šírová, et al.
Journal of Cell Science|November 24, 2021
Retraction: Identification and characterization of GRIM-1, a cell-death-associated gene productEdward R Hofmann, Shreeram C Nallar, Limei Lin, et al.
Ejhaem|January 29, 2025
Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferationXiaoxian Zhao, Deepa Jagadeesh, Juraj Bodo, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administrationS N Pavlou, K D Dahl, G Wakefield, et al.
In Vivo (Athens, Greece)|January 14, 1998
PET with hydroxytryptophan as tracer in hormone-refractory prostatic adenocarcinoma: evaluation of decarboxylation in vivoK M Kälkner, S Nilsson, M Bergström, et al.
Synapse (New York, N.Y.)|January 1, 1997
L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primatesJ Tedroff, R Torstenson, P Hartvig, et al.
Diabetologia|December 1, 1996
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upM Hanefeld, S Fischer, U Julius, et al.
Pageof 42